Publicacions (30) Publicacions de María del Consuelo Pintado Delgado

2024

  1. Respiratory Complications in the Immediate Postoperative Period after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Nowadays: An Observational Study

    Indian Journal of Critical Care Medicine, Vol. 28, Núm. 10, pp. 952-957

  2. Side-Effects on the Renal function of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

    International journal of medical sciences, Vol. 21, Núm. 13, pp. 2537-2543

2023

  1. Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    Journal of Clinical Medicine, Vol. 12, Núm. 13

  2. Medication errors reported in an adult Intensive Care Unit in a level 2 hospital in Spain

    Medicina Intensiva, Vol. 47, Núm. 12, pp. 736-738

  3. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 5, pp. 465-476

2022

  1. Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies

    The Lancet Global Health, Vol. 10, Núm. 2, pp. e227-e235

  2. Mechanical ventilation in patients with cardiogenic pulmonary edema: a sub-analysis of the LUNG SAFE study

    Journal of Intensive Care, Vol. 10, Núm. 1

  3. Prognostic tools at hospital arrival in acute myocardial infarction: copeptin and hepatocyte growth factor

    Egyptian Heart Journal, Vol. 74, Núm. 1

  4. Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis

    The Lancet Respiratory Medicine, Vol. 10, Núm. 4, pp. 367-377

2021

  1. Death in hospital following ICU discharge: insights from the LUNG SAFE study

    Critical Care, Vol. 25, Núm. 1

  2. Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

    The Lancet Infectious Diseases, Vol. 21, Núm. 9, pp. 1313-1323

  3. Serum hepatocyte growth factor as diagnostic tool in patients with acute chest pain

    Revista Colombiana de Cardiologia, Vol. 28, Núm. 6, pp. 564-572

2020

  1. Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: Insights from the LUNG SAFE study

    Critical Care, Vol. 24, Núm. 1

2019

  1. Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study

    Anesthesiology, Vol. 130, Núm. 2, pp. 263-283

  2. Substance withdrawal in ICU environment

    Oncologic Critical Care (Springer International Publishing), pp. 1913-1933

2018

  1. Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study (Intensive Care Medicine, (2016), 42, 12, (1865-1876), 10.1007/s00134-016-4571-5)

    Intensive Care Medicine

  2. Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries

    Critical Care, Vol. 22, Núm. 1

  3. Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database

    Critical Care, Vol. 22, Núm. 1

  4. Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database

    Critical Care, Vol. 22, Núm. 1

  5. Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study

    Intensive Care Medicine, Vol. 44, Núm. 5, pp. 564-577